The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?
Physiology
[키워드] Activation
addition
Affect
antibody
antigen presenting cell
Antiviral
beneficial microbes
caused
cellular and molecular
Characteristics
Coagulation
coronavirus
Course
death
Defense
demonstrated
detrimental effect
distal
emerging respiratory virus
ENhance
example
Factor
Health
immune response
Immunity
immunobiotics
Infectious disease
Inflammation
information
intestinal
involved
knowledge
Lactobacillus rhamnosus
lung
mandatory
mechanism
microbial
microbiota
microorganism
mitigate
modulate
morbidity and mortality
mucosal
new SARS-CoV-2
nutritional intervention
populations
Prevent
reducing
regulate
reported
Research
respiratory epithelial cell
respiratory infection
respiratory tract
respiratory viral infections
respiratory virus
response
SARS-CoV-2 virus
Spread
stimulate
strain
Th1 response
the SARS-CoV-2
the WHO
therapeutic
tissue damage
type I interferon
Variation
viral infection
virus
[DOI] 10.3389/fphys.2020.00699 PMC 바로가기 [Article Type] Physiology
[DOI] 10.3389/fphys.2020.00699 PMC 바로가기 [Article Type] Physiology